Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of rhamnosidase tperha mutant and its preparation method and application

A rhamnosidase, tperha-k579a technology, applied in the field of biomedicine, can solve the problems of unknown content of icariside I and inability to efficiently catalyze conversion, and achieve the effect of short enzymatic hydrolysis time and high conversion rate

Active Publication Date: 2021-09-03
FOSHAN GOLDEN HEALTH TECH CO LTD
View PDF10 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The patent number is CN201710448315.6, which is a Chinese patent titled a glycosidase composition and a method for enzymatically preparing icarigenin, which prepares epimedium by α-L-rhamnosidase and β-glucosidase Huorigenin, which has a high conversion rate of icariin, but the content of icariside Ⅰ is unknown
The patent number is CN201710332977.7, and the name is a method for enzymatically transforming total flavonoids of Epimedium to prepare icariin. The enzyme system synergistically converts the multi-component flavonoid glycosides in the total flavonoids of Epimedium to produce icariin, but cannot efficiently catalyze the conversion to icariside Ⅰ

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of rhamnosidase tperha mutant and its preparation method and application
  • A kind of rhamnosidase tperha mutant and its preparation method and application
  • A kind of rhamnosidase tperha mutant and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0048] Establishment of TpeRha enzyme tertiary structure model and determination of mutation sites:

[0049] (1) Establish a three-dimensional structural model of TpeRha

[0050] The homology modeling tool MODELLER was used to carry out homology modeling on TpeRha. After the model was evaluated, a reliable 3D structural model was obtained according to the scoring criteria. The 3D structural model is as follows: figure 1 shown.

[0051] (2) Determination of mutation sites

[0052] Such as figure 2 As shown, the three-dimensional structure model of TpeRha obtained by homology modeling was established based on the three-dimensional structure model of Dictyoglomusthermophilum α-L-rhamnosidase DtRha (PDB ID: 6i60). Studies have shown that in the crystal structure model of DtRha enzyme and glycoside ligand, there are 11 amino acid residues that interact with rhamnosyl. The conformational comparison of the TpeRha enzyme and the three-dimensional structure model of the DtRha enzy...

Embodiment 2

[0054] Obtaining of recombinant wild enzyme strain BL21(DE3) / pET-28a-TpeRha:

[0055] Optimize the α-L-rhamnosidase gene from Thermotoga petroleum DSM 13995, its nucleotide sequence is as SEQ ID NO: 2 (GenBank: ABQ47687.1), connect it to the pET-28a plasmid, and obtain the recombinant The plasmid was named pET-28a-TpeRha, such as image 3 As indicated, the plasmid was transformed into Escherichia coli BL21 (DE3), and the recombinant strain was named BL21 (DE3) / pET-28a-TpeRha. The amino acid sequence of the wild type TpeRha enzyme expressed by the recombinant wild enzyme strain is shown in SEQ ID NO:1.

Embodiment 3

[0057] Obtaining of TpeRha mutant strains:

[0058] (1) Construction of mutant vectors by whole plasmid PCR

[0059] 1. A small amount of plasmid extraction of the recombinant plasmid pET-28a-TpeRha;

[0060] 2. Design mutation primers. The primers have a 15 bp overlapping region and a 15 bp extension region, and the mutation site is designed in the overlapping region. The plasmid pET-28a-TpeRha was used as a template for PCR amplification of the whole plasmid, and the PCR system is shown in Table 1:

[0061]

[0062] The primers Primer-F and Primer-R are PCR upstream primers and downstream primers designed according to different mutation sites, and the specific primer information is shown in Table 2.

[0063]

[0064] The primer pair H130A-F and H130A-R are used to obtain the mutant TpeRha-H130A, the amino acid sequence of the mutant TpeRha-H130A is SEQ ID NO:9.

[0065] The primer pair R369A-F and R369A-R are used to obtain mutant TpeRha-R369A, the amino acid sequen...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A rhamnosidase TpeRha mutant and its preparation method and application, the present invention relates to the technical field of biomedicine, which is any one of mutant TpeRha-R369A, mutant TpeRha-W512A and mutant TpeRha-K579A; Mutant TpeRha‑R369A, for the amino acid sequence of the 369th arginine of the TpeRha enzyme shown in SEQ ID NO: 1 is mutated to alanine; the mutant TpeRha‑W512A is for the amino acid sequence of the The tryptophan at position 512 of the TpeRha enzyme was mutated to alanine. The present invention constructs a combined mutant of α-L-rhamnosidase TpeRha by site-directed mutagenesis technology, and catalyzes the conversion of multi-component flavone glycosides in total flavonoids of Epimedium to prepare an icariside I composition, with short enzymatic hydrolysis time, High conversion rate.

Description

technical field [0001] The invention relates to the technical field of biomedicine, in particular to a rhamnosidase TpeRha mutant and its preparation method and application. Background technique [0002] Epimedium is a plant of the genus Epimedium in the family Berberidaceae. It is a traditional Chinese medicine recorded in the Chinese Pharmacopoeia. Epimedium flavonoid glycosides, Epimedium flavone glycosides have anti-cancer, anti-osteoporosis, anti-aging, immune regulation functions and kidney-yang effects. A large number of studies have shown that epimedium flavonoid glycosides such as epimedin C and icariin are poorly absorbed in the small intestine, and they are mainly absorbed in the form of intestinal metabolites (secondary glycosides or aglycones) to exert their curative effect. Therefore, the stable and controllable hydrolysis of epimedium flavonoid glycosides and the effective biotransformation of epimedium flavonoid glycosides are of great significance for stren...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N9/24C12N15/56C12N15/10C12N15/70C12P19/60C12R1/19
CPCC12N9/2402C12N15/1031C12N15/70C12N2800/22C12P19/60C12Y302/0104C12Q2531/113
Inventor 黄佳俊李慧灵胡浩轩林育成卢宇靖周金林
Owner FOSHAN GOLDEN HEALTH TECH CO LTD